.png)
AstraZeneca is a global, science-based biopharmaceutical company dedicated to the discovery, development, and commercialization of prescription medicines. Focusing on three key therapy areas—Oncology, Cardiovascular, Renal and Metabolism, and Respiratory—the company is at the forefront of medical innovation. As one of the top 10 multinational pharmaceutical companies in the Philippines, AstraZeneca has led the industry in clinical trials conducted in the country from 2019 to 2021.
AstraZeneca prioritizes patient well-being while recognizing the interconnectedness of health, sustainability, and business. This commitment extends beyond medicine to holistic healthcare solutions, ensuring accessible and sustainable treatments for Filipinos. Addressing the rising burden of noncommunicable diseases (NCDs) like Lung Cancer, Type 2 Diabetes, and Asthma, AstraZeneca implements collaborative, community-focused initiatives to improve disease management and healthcare accessibility.
%2C%20INC..png)
Transforming Disease Management Across Key Therapy Areas
In the cardiovascular, renal, and metabolism sector, AstraZeneca supports the ACT Now for Diabetes program in partnership with Diabetes Philippines. This initiative works alongside local government units to identify high-risk diabetic patients, educate healthcare professionals, and empower patients with knowledge for better disease management. The Beyond Sugar social media campaign further raises awareness about Type 2 diabetes and its impact on vital organs, reaching millions of Filipinos.
For respiratory health, the Juan Healthy Lung program enhances asthma management through patient, physician, and pharmacist education. AstraZeneca leverages digital platforms such as the Breathe Better campaign to provide content that helps Filipinos manage their asthma effectively.
In oncology, AstraZeneca’s Lung Ambition Alliance establishes a comprehensive healthcare ecosystem to reduce lung cancer morbidity and mortality. The program pioneers AI-assisted chest x-ray screenings, promotes early detection, and supports a national cancer triage hotline in collaboration with leading medical organizations. Through the LVNG with Lung campaign, AstraZeneca fosters a support community that educates, inspires, and uplifts lung cancer patients and their families.
Strengthening Public Health and Pandemic Response
AstraZeneca played a vital role in the fight against COVID-19, facilitating a multilateral agreement that united the Philippine government, local authorities, and private donors in a nationwide immunization effort. Beyond vaccine distribution, AstraZeneca continues to push the boundaries of science to elevate healthcare standards, ensuring long-term benefits for Filipino families.
AstraZeneca Philippines exemplifies a deep-rooted commitment to advancing healthcare through scientific innovation, collaboration, and sustainability. By integrating cutting-edge medical solutions with a strong patient-first approach, the company continues to shape the future of healthcare in the Philippines.
